TMOHIGH SIGNALFINANCIAL10-K

TMO reported extraordinary 309% revenue growth to $20.9B, likely driven by a major acquisition, accompanied by significant debt increases and cash position strengthening.

The massive revenue jump from $5.1B to $20.9B strongly indicates a transformational acquisition that has fundamentally altered TMO's scale and financial profile. While debt increased substantially to $39.2B (+26%), the company maintained strong liquidity with cash rising to $9.9B, suggesting careful financial management of this major transaction.

Comparing 2026-02-26 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

TMO underwent a dramatic transformation with revenue exploding 309% to $20.9B while total assets grew a more modest 13% to $110.3B, indicating significant operational leverage from likely acquisition activity. The company funded growth through increased debt (+26% to $39.2B) and higher interest expense (+89%), but maintained financial flexibility with cash surging 146% to $9.9B and reduced share buybacks to $3.0B. This financial profile suggests a major strategic acquisition that has dramatically expanded TMO's revenue base while the company maintains adequate liquidity to service the increased debt load.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+308.9%
$5.1B→$20.9B

Strong top-line growth of 308.9% — accelerating demand or successful expansion into new markets.

Cash & Equivalents
Balance Sheet
+145.7%
$4.0B→$9.9B

Cash position surged 145.7% — strong cash generation or capital raise providing significant financial cushion.

Interest Expense
P&L
+89.4%
$726.0M→$1.4B

Interest expense surged 89.4% — significant debt increase or rising rates materially impacting earnings.

Current Assets
Balance Sheet
+29.7%
$22.1B→$28.7B

Current assets grew 29.7% — improving short-term liquidity or inventory/receivables build.

Total Debt
Balance Sheet
+26.1%
$31.1B→$39.2B

Debt rose 26.1% — additional borrowing for investment or operations; monitor coverage ratios.

Share Buybacks
Cash Flow
-25%
$4.0B→$3.0B

Buyback activity reduced 25% — capital being redeployed elsewhere or cash conservation underway.

Current Liabilities
Balance Sheet
+13.9%
$13.3B→$15.2B

Current liabilities rose 13.9% — increased short-term obligations, watch current ratio.

Total Assets
Balance Sheet
+13.4%
$97.3B→$110.3B

Asset base grew 13.4% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-20
ADDED
As of January 31, 2026, the Registrant had 371,484,244 shares of Common Stock outstanding.
Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, and are often identified by words such as expects, anticipates, intends, plans, believes, seeks, estimates, may, will, should, or similar expressions or words with similar meanings.
Any statements contained herein that are not statements of historical fact should be considered forward-looking statements.
Important risks and uncertainties that could cause such differences are detailed under the heading, Risk Factors in Part I, Item 1A.
While the company may elect to update forward-looking statements in the future, it specifically disclaims any obligation to do so, in the event of new information, future developments, or otherwise, except as required by law.
+7 more — sign up free →
REMOVED
As of February 1, 2025, the Registrant had 377,261,182 shares of Common Stock outstanding.
Without limiting the foregoing, the words believes, anticipates, plans, expects, seeks, estimates, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words.
While the company may elect to update forward-looking statements in the future, it specifically disclaims any obligation to do so, even if the company s estimates change, and readers should not rely on those forward-looking statements as representing the company s views as of any date subsequent to the date of the filing of this report.
A number of important factors could cause the results of the company to differ materially from those indicated by such forward-looking statements, including those detailed under the heading, Risk Factors in Part I, Item 1A.
Life Sciences Solutions includes three primary businesses Biosciences, Genetic Sciences, and BioProduction.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →